πŸ‡ΊπŸ‡Έ FDA
Patent

US 8426461

Orally dispersible tablet

granted A61KA61K31/343A61K47/26

Quick answer

US patent 8426461 (Orally dispersible tablet) held by Takeda Pharmaceutical Company Limited expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/343, A61K47/26, A61K47/38, A61K47/40